AGÕæÈ˹ٷ½

STOCK TITAN

TransMedics to Present at Upcoming June Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

TransMedics (Nasdaq: TMDX), a medical technology company focused on organ transplant therapy, has announced its participation in two major investor conferences in June 2025. The company will present at the William Blair 45th Annual Growth Stock Conference in Chicago on June 3 at 5:00 p.m. EST and participate in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference in Miami on June 9 at 8:00 a.m. EST. Both presentations will be available via webcast on TransMedics' investor relations website.

TransMedics (Nasdaq: TMDX), un'azienda di tecnologia medica specializzata nella terapia dei trapianti d'organo, ha annunciato la sua partecipazione a due importanti conferenze per investitori nel giugno 2025. La società presenterà al William Blair 45th Annual Growth Stock Conference a Chicago il 3 giugno alle 17:00 EST e parteciperà a una tavola rotonda informale al Goldman Sachs 46th Annual Global Healthcare Conference a Miami il 9 giugno alle 8:00 EST. Entrambe le presentazioni saranno disponibili in webcast sul sito web delle relazioni con gli investitori di TransMedics.

TransMedics (Nasdaq: TMDX), una empresa de tecnología médica centrada en la terapia de trasplantes de órganos, ha anunciado su participación en dos importantes conferencias para inversores en junio de 2025. La compañía presentará en la William Blair 45th Annual Growth Stock Conference en Chicago el 3 de junio a las 5:00 p.m. EST y participará en una charla informal en la Goldman Sachs 46th Annual Global Healthcare Conference en Miami el 9 de junio a las 8:00 a.m. EST. Ambas presentaciones estarán disponibles vía webcast en el sitio web de relaciones con inversores de TransMedics.

TransMedics(나스ë‹�: TMDX)ëŠ� 장기 ì´ì‹ 치료ì—� 중ì ì� ë‘� ì˜ë£Œ 기술 회사ë¡�, 2025ë…� 6ì›� ë‘� ê°œì˜ ì£¼ìš” 투ìžìž� 컨í¼ëŸ°ìФì—� 참여한다ê³� 발표했습니다. 회사ëŠ� 6ì›� 3ì� 오후 5ì‹�(EST)ì—� 시카고ì—ì„� 열리ëŠ� William Blair 45th Annual Growth Stock Conferenceì—서 발표ë¥� 진행하며, 6ì›� 9ì� 오전 8ì‹�(EST) 마ì´ì• ë¯¸ì—서 열리ëŠ� Goldman Sachs 46th Annual Global Healthcare Conferenceì—서 파ì´ì–´ì‚¬ì´ë“œ 채팅ì—� 참여í•� 예정입니ë‹�. ë‘� 발표 ëª¨ë‘ TransMedics 투ìžìž� ê´€ê³� 웹사ì´íЏë¥� 통해 웹ìºìŠ¤íŠ¸ë¡� 제공ë©ë‹ˆë‹�.

TransMedics (Nasdaq : TMDX), une entreprise de technologie médicale spécialisée dans la thérapie de transplantation d'organes, a annoncé sa participation à deux grandes conférences pour investisseurs en juin 2025. La société présentera lors de la William Blair 45th Annual Growth Stock Conference à Chicago le 3 juin à 17h00 EST et participera à une discussion informelle lors de la Goldman Sachs 46th Annual Global Healthcare Conference à Miami le 9 juin à 8h00 EST. Les deux présentations seront disponibles en webcast sur le site des relations investisseurs de TransMedics.

TransMedics (Nasdaq: TMDX), ein Medizintechnikunternehmen mit Schwerpunkt auf Organtransplantationstherapie, hat seine Teilnahme an zwei wichtigen Investorenkonferenzen im Juni 2025 angekündigt. Das Unternehmen wird am William Blair 45th Annual Growth Stock Conference in Chicago am 3. Juni um 17:00 Uhr EST präsentieren und an einem Fireside-Chat auf der Goldman Sachs 46th Annual Global Healthcare Conference in Miami am 9. Juni um 8:00 Uhr EST teilnehmen. Beide Präsentationen werden per Webcast auf der Investor-Relations-Website von TransMedics verfügbar sein.

Positive
  • None.
Negative
  • None.

ANDOVER, Mass., May 20, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced the company will be participating in two upcoming investor conferences. TransMedics management is scheduled to present at the William Blair 45th Annual Growth Stock Conference in Chicago on Tuesday, June 3, 2025, at 5:00 p.m. EST and participate in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference in Miami on Monday, June 9, 2025, at 8:00 a.m. EST.

Event: William Blair 45th Annual Growth Stock Conference
Date: Tuesday, June 3, 2025
Time: 5:00 p.m. EST

Event: Goldman Sachs 46th Annual Global Healthcare Conference
Date: Monday, June 9, 2025
Time: 8:00 a.m. EST

A live and archived webcast of the presentations will be available on the "Investors" section of the TransMedics website at . The Company's standard investor presentation is also available through this link.

About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Investor Contact:
Brian Johnston
Laine Morgan
332-895-3222
[email protected]

Cision View original content to download multimedia:

SOURCE TransMedics Group, Inc.

FAQ

When and where will TransMedics (TMDX) present at the William Blair Conference in 2025?

TransMedics will present at the William Blair 45th Annual Growth Stock Conference in Chicago on Tuesday, June 3, 2025, at 5:00 p.m. EST.

What time is TransMedics' (TMDX) presentation at the Goldman Sachs Healthcare Conference 2025?

TransMedics will participate in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference on Monday, June 9, 2025, at 8:00 a.m. EST.

How can investors access TransMedics' (TMDX) conference presentations?

Investors can access live and archived webcasts of the presentations through the 'Investors' section of TransMedics' website at https://investors.transmedics.com/.

What type of company is TransMedics (TMDX)?

TransMedics is a medical technology company that develops therapy for patients with end-stage lung, heart, and liver failure through organ transplant solutions.
Transmedics Group

NASDAQ:TMDX

TMDX Rankings

TMDX Latest News

TMDX Latest SEC Filings

TMDX Stock Data

3.64B
32.81M
3.5%
115.88%
27.72%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
United States
ANDOVER